The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $134.33

Today's change-0.32 -0.24%
Updated January 13 4:02 PM EST. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $134.33

Today's change-0.32 -0.24%
Updated January 13 4:02 PM EST. Delayed by at least 15 minutes.

Reversal following new 50-day high

Laboratory Corporation of America Holdings closed lower Friday, dropping (U.S.)$0.32 or 0.24% to (U.S.)$134.33 after setting a new 50-day high. Over the last five days, shares have gained 3.86% and are currently 4.95% off of the 52-week high. Over the last year, this stock has performed in-line with the S&P 500, gaining 20.18%.

Key company metrics

  • Open(U.S.) $134.31
  • Previous close(U.S.) $134.65
  • High(U.S.) $135.99
  • Low(U.S.) $134.12
  • Bid / Ask-- / --
  • YTD % change+4.63%
  • Volume670,548
  • Average volume (10-day)826,509
  • Average volume (1-month)702,535
  • Average volume (3-month)739,817
  • 52-week range(U.S.) $97.79 to (U.S.) $141.32
  • Beta0.94
  • Trailing P/E21.19×
  • P/E 1 year forward15.25×
  • Forward PEG1.49×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $6.34
Updated January 13 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.97%

Based on its net profit margin of 6.97%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.17%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue2,4152,4312,3682,301
Total other revenue--------
Total revenue2,4152,4312,3682,301
Gross profit788827777741
Total cost of revenue1,6261,6041,5911,560
Total operating expense2,0912,0642,0662,057
Selling / general / administrative401408412405
Research & development--------
Depreciation / amortization41454438
Interest expense (income), net operating--------
Unusual expense (income)2371954
Other operating expenses, total--------
Operating income324367302243
Interest income (expense), net non-operating-58-54-55-57
Gain (loss) on sale of assets--------
Other--------
Income before tax263313256186
Income after tax180199161115
Income tax, total841159672
Net income180198160114
Total adjustments to net income--------
Net income before extra. items180198160114
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items180198160114
Inc. avail. to common incl. extra. items180198160114
Diluted net income180198160114
Dilution adjustment----0--
Diluted weighted average shares105104104103
Diluted EPS excluding extraordinary itemsvalue per share1.711.911.551.11
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.861.951.661.43